Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Dermatologic 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Hodgkin Disease 1Epstein-Barr Virus Infections 1

Interventions

Blood Specimen Collection 15Imatinib Mesylate 10Flow Cytometry 10nilotinib 8Surveys and Questionnaires 8Polymerase Chain Reaction 8ponatinib 6Cytogenetic Analysis 6ruxolitinib 5bosutinib 5Psychiatric Rehabilitation 5Dasatinib 5Therapeutics 4Interviews as Topic 4Biopsy 4asciminib 3Observation 3Microarray Analysis 3In Situ Hybridization, Fluorescence 3Immunoenzyme Techniques 3Amplified Fragment Length Polymorphism Analysis 3olverembatinib 2fludarabine 2Watchful Waiting 2Tyrosine Kinase Inhibitors 2Molecular Diagnostic Techniques 2Influenza Vaccines 2Immunologic Techniques 2Immunohistochemistry 2Hydroxyurea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × In Situ Hybridization × Myeloid × Clear all
NCT01490801 2016-05-17

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Children's Oncology Group

Completed
50 enrolled
LymphoidMyeloid

Hodgkin Disease, Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡